Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Oncothyreon
Xoma
Amarin
Opexa
Human Genome
Seattle Genetics
Vertex Pharmaceuticals
Merck
Dendreon
Biogen Idec
Amgen
Pharmasset
Drug Stocks Ended Mostly Lower (King Pharmaceuticals, AMGN, ARNA, XOMA)
Wall Street Bay
Sun, 01/2/11 - 12:24 pm
King
Amgen
Arena Pharmaceuticals
Xoma
2011 Big-Cap Biotech Preview
TheStreet.com
Wed, 12/22/10 - 09:21 am
biotech
Celgene
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Sanofi
Drug Companies Stocks Underperfomed: AMGN, NVO, JNJ
Trader's Huddle
Sat, 12/18/10 - 12:44 pm
Amgen
Novo Nordisk
JNJ
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Sat, 12/18/10 - 12:35 pm
Xgeva
Amgen
prostate cancer
Zometa
Amgen Celebration May be Premature
Minyanville
Tue, 12/14/10 - 09:46 pm
Amgen
prostate cancer
Xgeva
Amgen shares rise after positive study data
Marketwatch
Tue, 12/14/10 - 11:11 am
Amgen
prostate cancer
Xgeva
Amgen Drug Prevents Prostate Cancer From Spreading To Bone
Forbes
Mon, 12/13/10 - 09:14 pm
Amgen
prostate cancer
Xgeva
Amgen, Actelion Talk but No Offer Made
TheStreet.com
Mon, 12/13/10 - 10:13 am
Amgen
Actelion
M&A
Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Yahoo/PR NewsWire
Sat, 12/11/10 - 11:41 am
Amgen
denosumab
Xgeva
breast cancer
Actelion Wants to Remain Independent, CEO Clozel Says
Bloomberg
Sat, 12/11/10 - 10:49 am
M&A
Amgen
Actelion
Pharmaceuticals Pregnant and Overdue
Seeking Alpha
Wed, 12/8/10 - 02:14 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
JNJ
Merck
Mylan
Pfizer
How Cheap Is Amgen's Stock by the Numbers?
Motley Fool
Sat, 12/4/10 - 12:20 pm
Amgen
investors
The Amgen Sales Rep, The Doctor And The Dog
Pharmalot
Wed, 12/1/10 - 12:10 pm
Amgen
drug reps
physicians
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
RNAi
Merck
Alnylam
Pfizer
Amgen
Novartis
Eli Lilly
Roche
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
M&A
Abbott Laboratories
Actelion
GSK
JNJ
Roche
Amgen
Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Amgen
M&A
Actelion
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Genzyme
Actelion
Sanofi
M&A
Bayer
Amgen
AstraZeneca
Pages
« first
‹ previous
…
88
89
90
91
92
93
94
95
96
…
next ›
last »